Leerink Swann Reiterates an 'Outperform' on Jazz Pharmaceuticals (JAZZ); Xyrem Patent Strengthens
Go back to Leerink Swann Reiterates an 'Outperform' on Jazz Pharmaceuticals (JAZZ); Xyrem Patent Strengthens| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 244.96 -0.89 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.85 | 52 Week High | $160.00 | |||
| Open | $243.59 | 52 Week Low | $95.80 | |||
| Day High | $245.35 | P/E | 45.53 | |||
| Day Low | $240.63 | EPS | $5.38 | |||
| Volume | 542,032 | |||||
